Protagonist Therapeutics, Inc.
- PTGX
- NASDAQ
- Biotechnology
- Peptide-Based Therapies
- Hematology & Inflammatory Diseases
$128.75
Today −5.71%Quote Oct 16, 2026, 08:00 PM UTC
−10.40%over the last month
Max drawdown −11.2%From 1-month high −11.2%3 months −4.1%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$8.33B
Quote Oct 16
Next earnings
Nov 5
Expected, not confirmed
Analyst target
$177.25
+37.7% from here
Floor
$127.57
0.9% below price
Where the price sits
26 analysts
Analyst range, low to high
$165.00$190.00
- Price $128.75
- Resistance $131.83
- Consensus $177.25
The price is just above its floor and right under resistance. Analysts' average target sits about 38% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about PTGXPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
141
Founded
2006